PegBio 派格生物 IPO: PHIP Updates Don’t Look Good
PegBio plans to raise up to $100m for a Hong Kong listing. We compared the filings and noted massive delays and more competitors joining the race.
380 Views
PegBio (派格生物) IPO: Thoughts on Valuation
China's PegBio seeks to raise $150 million through Hong Kong listing. In this note, we provide an valuation framework for its key product PB-119.
303 Views
PegBio 派格生物 IPO: A (Supposedly) Straightforward GLP-1 Challenger Story
PegBio plans to raise $100m in Hong Kong IPO, with focus on core product PB-117 as a GLP-1 challenger, but concerns arise upon closer examination...
312 Views
Pre-IPO PegBio Co., Ltd. (PHIP Updates) - Some Points Worth the Attention
Market expectations for PegBio's GLP-1 pipelines are changing, casting doubt on valuation. PB-119 faces tough competition in a crowded market. We...
338 Views
ECM Weekly (10th Mar 2025) - BYD, Japan Post, Mixue, Sanhua, Chifeng, Nanshan, Goertek, Travel Food
Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.
433 Views